Blood Glucose Monitoring Developments Focus on Mobility, Convenience

According to the Centers for Disease Control and Prevention (CDC) more than 29 million U.S. residents have diabetes. The agency also reports that medical costs for diabetics are twice as high as nondiabetics. For the diagnostics industry, these statistics indicate a need for products that can help patients monitor their blood sugar and cope with their diabetes. To better manage the disease, diagnostics are striving to make blood glucose testing more convenient and more mobile. FDA approves new Bluetooth connected mobile system In late November, the U.S. Food and Drug Administration (FDA) granted Ascensia Diabetes Care approval to market the CONTOUR® NEXT ONE Blood Glucose Monitoring System (BGMS), a Bluetooth connected meter that connects to a mobile app. The app stores and analyzes blood glucose measurements taken by the meter to help patients monitor and manage their blood glucose. Ascensia announced the FDA approval and indicated it expects to bring the device to market early next year. Here are some details about the system: App is downloadable from Apple App Store and Google Play 95% of results within ±8.4 mg/dL or ±8.4% of laboratory reference values for glucose concentrations < 100 mg/dL or ≥ 100 mg/ dL (fingerstick) Meter provides […]